|
|
|
| home > ebr > Spring 2006 |
|
|
 PUBLICATIONS |
|
|
 |
News and Press Releases |
 |
PTC Therapeutics Reports the Initiation of the Second Stage of the FITE19 Phase 2/3 Clinical Trial Evaluating PTC299 for the Treatment of COVID-19
PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced the initiation of
the second stage of the FITE19 clinical trial to assess PTC299 in
COVID-19 patients. PTC299 is an oral investigational drug with a novel
dual mechanism of action that has the potential to inhibit viral
replication and attenuate the uncontrolled inflammatory response that
ensues after infection.
More info >> |
|
 |
White Papers |
 |
|
The Key To Tableting Success: How To Choose The Right Tooling
Natoli Engineering Company, Inc.
Choosing the right tooling can increase tablet output, decrease waste and ultimately determine the success of a product launch.
More info >> |
|
 |
Industry Events |
 |
World Vaccine Congress Washington 2021
4-6 May 2021, VIRTUAL CONFERENCE
For the past 21 years, the World Vaccine Congress Washington congress
has evolved and grown into the leading vaccines congress globally, with
hundreds of speakers, thousands of attendees and hundreds of networking
opportunities
More info >> |
|
|
.jpg)
